Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-07-11
2006-07-11
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C548S435000
Reexamination Certificate
active
07074831
ABSTRACT:
Compounds of formula (I)for clinical treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection and malignant neoplasia. A pharmaceutical composition comprising a compound of formula (I) in an amount giving a daily dosage of from 0.005 mg/kg to 10 mg/kg body weight, in particular from 0.025 mg/kg to 2 mg/kg body weight.
REFERENCES:
patent: 4307113 (1981-12-01), Anderson
patent: 2 064 305 (1972-07-01), None
patent: 102 54 872 (2004-06-01), None
patent: 0 034 292 (1981-08-01), None
patent: 0 181 568 (1986-05-01), None
patent: WO 97/28118 (1997-08-01), None
Sevbo, D.P. et al., 2-Amino-3-phenothiazone deriviatives. III. Methyl 2-amino-3-phenothiazone-1-carboxylate. (1976) Zhurnal Organischeskoi Khimii, vol. 12, No. 8, pp. 1819-15.
Batt, Douglas G. “Inhibitors of dihydroorotate dehydrogenase” Exp. Opin. Ther. Patents (1999) vol. 9, No. 1, pp.: 41-54.
Breedveld, Ferdinand C. “New Insights in the Pathogenesis of Rheumatoid Arthritis” The Journal of Rheumatology (1998) vol. 25, supplement 53, pp.: 3-7.
Bruneau, Jean-Michel et al “Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide” Biochem, J. (1998) 336 pp.: 299-303.
Chan, Dominic M.T. et al “New N- and O-Ariations with Phenylboronic Acids and Cupric Acetate” Tetrahedron Letters 39 (1998) pp.: 2933-2936.
Cherwinski, Holly M. “The Immunosuppressant Leflunomide Inhibits Lymphocyte Proliferation by Inhibiting Pyrimindine Biosynthesis” The Journal of Pharmacology and Experimental Therapeutics, vol. 275, No. 2 (1995) pp.: 1043-1049.
Gennari, Mara et al “Anaerobic Degradation of Acifluorfen by Different Enrichment Cultures” J. Agric. Food Chem, (1994) vol. 42, pp.: 1232-1236.
Hutchinson, John H. et al “Non-Peptide Glycoprotein IIb/IIIa Antagonists. 11. Design and in Vivo Evaluation of 3,4-Dihydro-1(1H)-isoquinolinone-Based Antagonists and Ethyl Ester Prodrugs” J. Med. Chem. (1996) vol. 39 pp.: 4583-4591.
Kubinyl, Hugo “QSAR: Honsch Analysis and Related Approaches” (1993) ISBN 1-56081-768-2 (VCH) “Chapter 3: Parameters” pp.: 21-27.
Mathis, Chester A. “Synthesis and Evaluation of11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents” J. Med. Chem. (2003) vol. 46, pp.: 2740-2754.
Ohnmacht, Cyrus J. et al “N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropoanamides: KATP Potassium Channel Openers. Modifications on the Western Region” J. Med. Chem., vol. 39 (1996) p. 4592-p. 4601, tables 1-4.
Patil, Sharadbala D et al “Folate Analogues. 32. Synthesis and Biological Evaluation of 2-Desamino-2-methyl-N10-propargyl-5,8-dideazafolic Acid and Related Compounds” J. Med. Chem. (1989) vol. 32 pp.: 1284-1289.
Remington's pharmaceutical sciences. Ed. 17, Alfonso R. Gennaro, editor, Easton: Mack Pub. Co., 1985-“Lists of suitable salts are found in . . . ”.
Research Disclosure Synthetic analogues of the partial structure of the natural product lavendustin A (Author: Novartis Forschungsinstitut GmbH A-I 230 Vienna, Austria) Research Disclosure Database No. 409053. Published in May 1998.
Sevbo, D.P. et al “2-Amino-3-phenothiazone derivatives. III. Methyl 2-amino-3-phenothiazone-1-carboxylate.” (1976) Zhurnal Organischeskoi Khimii, vol. 12, No. 8 pp. 1819-1825 ISSN: 0514-7492 *Abstract.
Staiger, Roger P. et al “Isatoic Anhydrde. IV. Reaction with Various Nucleophile” Isatoic Anhydride IV, vol. 24, (Sep. 1959) pp.: 1214-1219.
Vinod Kumar Pandey et al “Synthesis and antiviral activity of quinazolyl thiatriazoles”, Acta Pharm. vol. 52, 2002, p. 129-p. 136, compound 1, p. 133.
Andersson Gunnar
Fritzson Ingela
Jönsson Stig
Wellmar Ulf
Active Biotech AB
Barker Michael
Browdy and Neimark PLLC
Saeed Kamal A.
LandOfFree
Compounds, methods for their preparation and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, methods for their preparation and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, methods for their preparation and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3590365